| Literature DB >> 32670198 |
Flavio A Cadegiani1, Claudio E Kater1.
Abstract
Objectives: Physiological hormonal adaptions in athletes and pathological changes that occur in overtraining syndrome among athletes are unclear. The Endocrine and Metabolic Responses on Overtraining Syndrome (EROS) study evaluated 117 markers and unveiled novel hormonal and metabolic beneficial adaptive processes in athletes. The objective of the present study was to uncover which modifiable factors predict the behaviors of clinical and biochemical parameters and to understand their mechanisms and outcomes using the parameters evaluated in the EROS study.Entities:
Keywords: Endocrine and Metabolic Responses on Overtraining Syndrome (EROS) study; endocrinology of physical activity; hormonal conditioning; hormones and sports; overtraining syndrome; sports endocrinology
Mesh:
Year: 2020 PMID: 32670198 PMCID: PMC7332731 DOI: 10.3389/fendo.2020.00414
Source DB: PubMed Journal: Front Endocrinol (Lausanne) ISSN: 1664-2392 Impact factor: 5.555
Markers evaluated by the EROS study and included in the present analysis.
| Basal ACTH and cortisol and their response to an insulin tolerance test (ITT) | (1) Basal ACTH (pg/mL), and (2) cortisol (μg/dL) |
| Cortisol response to a | (9) Cortisol at 30 min, and (10) at 60 min after injection |
| Salivary cortisol rhythm (SCR) | (11) Salivary cortisol (ng/dL) at awakening, and (12) 30 min after |
| GH and Prolactin response to an ITT | (1) Basal (GH) (μg/L), and (2) prolactin (ng/mL) |
| Glucose behavior during an ITT | (8) Basal serum glucose (mg/dL) |
| Hormonal markers | (1) Total testosterone (ng/dL), and (2) Estradiol (pg/mL) |
| Biochemical markers | (13) Erythrocyte sedimentation rate (ESR, mm/h), and (14) Hematocrit (%) |
| Ratios | (23) Testosterone-to-estradiol, and (24) Testosterone-to-cortisol ratios |
| General patterns | (1) Duration of night sleep (h), and (2) Self-reported sleep quality (0–10) |
| Eating patterns | (5) Calorie intake (kcal/kg/day) |
| Psychological patterns | (9) Profile of Mood State (POMS) questionnaire (total score: −32 to +120) |
| Body metabolism analysis | (16) Measured-to-predicted basal metabolic rate (BMR, %) |
| Body composition | (18) Body fat percentage (%), and (19) Muscle mass weight (kg) |
Figure 1Non-similar modifiable patterns and parameters included in the present analysis.
Modifiable patterns as independent predictors of hormonal responses to stimulations (multivariate linear regression analysis).
| Early cortisol response to an ITT (during hypoglycemia) (μg/dL) | 0.029 | 23.8% | (1) CHO intake (direct) ( | Cortisol (μg/dL) = 8.33 + 0.5 × (CHO intake) + 1.36 × (protein intake) |
| Late cortisol response (30′ after hypoglycemia) (μg/dL) | 0.0005 | 26.1% | (1) Presence of OTS (inverse) ( | Cortisol (μg/dL) = 17.86 – 3.81 (if OTS) |
| Early ACTH response to an ITT (during hypoglycemia) (pg/mL) | 0.012 | 17.5% | (1) Calorie intake (direct) ( | ACTH = −67.74 + 2.83 × (calorie intake) + 0.92 × (Total POMS) |
| Late ACTH response to an ITT (30′ after hypoglycemia) (pg/mL) | 0.007 | 19.9% | (1) Presence of OTS (inverse) ( | – |
| Cortisol response to an ITT (μg/dL) | 0.004 | 22.0% | (1) Presence of OTS (inverse) ( | – |
| Basal GH (μg/L) | 0.033 | 9.3% | (1) Extra-activities (inverse) ( | GH (μg/L) = 0.97 – 0.08 × (extra activities) |
| Early GH response to an ITT (during hypoglycemia) (μg/L) | 0.017 | 12.0% | (1) CHO intake (direct) ( | GH (μg/L) = −0.78 + 1.29 × (CHO intake) |
| Late GH response (30′ after hypoglycemia) (μg/L) | 0.0012 | 23.0% | (1) Presence of OTS (inverse) ( | – |
| Early prolactin response to an ITT (during hypoglycemia) (ng/mL) | 0.009 | 15.0% | (1) CHO intake (direct) ( | Prolactin (ng/mL) = 8.36 + 2.43 × (CHO intake) |
| Late prolactin response (30′ after hypoglycemia) (ng/mL) | 0.0002 | 37.8% | (1) Protein intake (direct) ( | Prolactin (ng/mL) = −28.49 + 1.60 × (CHO intake) + 10.64 × (protein intake) + 2.46 × (extra activities) |
| Prolactin response to an ITT (ng/mL) | 0.0133 | 17.0% | (1) Protein intake (direct) ( | Prolactin (ng/mL) = −356.25 + 108.6 × (protein intake) + 30.57 × (extra activities) |
CHO, Carbohydrate; ITT, Insulin tolerant test; POMS, Profile of mood states; BMR, Basal metabolic rate; T/E, Testosterone-to-estradiol; OTS, Overtraining syndrome; Calorie intake, kcal/kg/day; CHO intake, g(CHO)/kg/day; protein intake, g(protein)/kg/day; extra activities, working and/or studying hours besides training; sleep quality, self-reported sleep quality (0–10).
Modifiable patterns as independent predictors of body metabolism and composition (multivariate linear regression analysis).
| Fat oxidation (% of total BMR) | <0.0001 (together with body water and T/E ratio) | 58.8% | (1) Extra activities (inverse) ( | Fat oxidation = −66.96 + 2.30 × (body water) + 0.51 × (T/E ratio) – 4.99 × (extra activities) |
| Fat mass (%) | 0.0001 | 31.0% | (1) Protein intake (inverse) ( | Fat mass = 20.35 – 3.1 × (protein intake) |
| Muscle mass (%) | 0.0006 | 33.7% | (1) Protein intake (direct) ( | Muscle mass = 47.84 + 1.42 × (protein intake) – 3.47 (if OTS) |
| Body water (%) | <0.0001 | 50.5% | (1) Protein intake (direct) ( | Body water = 60.75 + 1.69 × (protein intake) – 0.12 × (calorie intake) – 5.77 (if OTS) |
| Visceral fat (cm2) | 0.0002 | 38.2% | (1) Calorie intake (direct) ( | Visceral fat = 47.4 – 11.9 × (protein intake) + 1.3 × (calorie intake) + 45.1 (if OTS) |
CHO, Carbohydrate; BMR, Basal metabolic rate; OTS, Overtraining syndrome; Calorie intake, kcal/kg/day; CHO intake, g(CHO)/kg/day; protein intake, g(protein)/kg/day; extra activities, working and/or studying hours besides training; sleep quality, self-reported sleep quality (0–10).
Figure 2Expected and actual predictions of each modifiable factor.
Figure 3Summary of the influences of modifiable patterns on clinical and biochemical behaviors.
Most remarkable findings of the EROS study in healthy athletes.
| | |
| Basal ACTH and cortisol and their response to an insulin tolerance test (ITT) | (1) Prompter cortisol response (compared to non-athletes and OTS-affected athletes) |
| Salivary cortisol rhythm (SCR) | (3) Higher salivary cortisol 30 min after awakening (compared to non-athletes and OTS-affected athletes) |
| | |
| GH response to an ITT | (4) Higher basal GH (compared to non-athletes and OTS-affected athletes) |
| Prolactin response to an ITT | (7) Prompter prolactin response (compared to non-athletes and OTS-affected athletes) |
| | |
| Hormonal markers | (9) Higher total testosterone (ng/dL) (compared to non-athletes and OTS-affected athletes) |
| Biochemical markers | (11) Lower lactate (compared to non-athletes and OTS-affected athletes) |
| Ratios | (13) Lower neutrophil-to-lymphocyte (compared to non-athletes and OTS-affected athletes) |
| | |
| General patterns | (14) Better self-reported sleep quality (compared to non-athletes and OTS-affected athletes) |
| Psychological patterns | (15) Better overall moods, and anger, confusion, vigor, depression, tension, and fatigue subscales (compared to non-athletes and OTS-affected athletes) |
| Body metabolism analysis | (16) Higher measured-to-predicted basal metabolic rate (BMR) (compared to non-athletes and OTS-affected athletes) |
| Body composition | (18) Lower body fat percentage (compared to non-athletes and OTS-affected athletes) |
Figure 4Proposed mechanisms for the impaired performance observed in prolonged low carbohydrate intake.
Modifiable patterns as independent predictors of basal hormones and biochemical parameters (multivariate linear regression analysis).
| Estradiol (pg/mL) | 0.008 | 20.3% | (1) Calorie intake (inverse) ( | Estradiol (pg/mL) = 50.28 – 0.68 × (calorie intake) + 2.32 × (CHO intake) |
| Testosterone-to-oestadiol ratio (T/E) | 0.0007 | 30.7% | (1) Presence of OTS (inverse) ( | T/E = 14.1 – 0.86 × (CHO intake) + 12.9 (in case of OTS) |
| Total nocturnal urinary catecholamines (mg/12 h) | 0.0187 | 11.7% | (1) Extra activities (direct) ( | Total NUC = 49.5 + 20.6 × (extra activities) |
| Dopamine (mg/12 h) | 0.0136 | 13.1% | (1) Extra activities (direct) ( | Dopamine = 25.7 + 20.1 × (extra activities) |
| Creatine kinase (CK) | 0.02 | 11.3% | (1) Calorie intake (inverse) ( | CK = 1488 – 20.5 × (calorie intake) |
| Lactate | 0.0035 | 22.9% | (1) Calorie intake (inverse) ( | Lactate = 1.62 – 0.02 × (calorie intake) |
| Neutrophils (/mm3) | 0.045 | 13.8% | (1) Calorie intake (inverse) ( | Neutrophils = 4210 – 60.7 × (calorie intake) + 154.4 × (CHO intake) – 1,724 (if OTS) |
| Lymphocytes (/mm3) | 0.025 | 10.8% | (1) Protein intake (inverse) ( | Lymphocytes = 2767 – 207 × (protein intake) |
CHO, Carbohydrate; T/E, Testosterone-to-estradiol; OTS, Overtraining syndrome; Calorie intake, kcal/kg/day; CHO intake, g(CHO)/kg/day; protein intake, g(protein)/kg/day; extra activities, working and/or studying hours besides training; sleep quality, self-reported sleep quality (0–10).
Modifiable patterns as independent predictors of moods and feelings (multivariate linear regression analysis).
| POMS confusion subscale | 0.0002 | 33.7% | (1) Sleep quality (inverse) ( | POMS confusion subscale = 15.25 – 0.92 × (sleep quality) – 0.1 × (calorie intake) |
| POMS depression subscale | 0.0001 | 30.8% | (1) Sleep quality (inverse) ( | POMS depression subscale = 17.22 – 1.66 × (sleep quality) |
| POMS vigor subscale | <0.0001 | 83.6% | (1) Sleep quality (direct) ( | POMS vigor subscale = 3.7 + 1.15 × (sleep quality) – 11.96 (if OTS) |
| POMS fatigue subscale | <0.0001 | 85.7% | (1) Sleep quality (direct) ( | POMS fatigue subscale = 24.5 – 0.9 × (sleep quality) + 15.3 (if OTS) |
| POMS tension subscale | <0.0001 | 42.8% | (1) Presence of OTS (direct) ( | – |
| Adrenergic symptoms (0–10) | 0.003 | 23.7% | (1) Calorie intake (direct) ( | Symptoms = −0.09 + 0.16 × (calorie intake) – 0.45 × (CHO intake) |
| Libido (0–10) | 0.018 | 11.9% | (1) Extra-activities (inverse) ( | Libido = 10.3 – 0.4 × (extra activities) |
CHO, Carbohydrate; POMS, Profile of mood states; OTS, Overtraining syndrome; Calorie intake, kcal/kg/day; CHO intake, g(CHO)/kg/day; protein intake, g(protein)/kg/day; extra activities, working and/or studying hours besides training; sleep quality, self-reported sleep quality (0–10).